AMD is mainly divided into two types: dry and wet. The dry form is characterized by retinal pigment changes and formation of Drusen, and gradually causes macular atrophy. The wet type is neovascular AMD, which is due to the formation of choroidal neovascularization in the macula, and causes hemorrhage and exudation. Both types can seriously affect the patient’s central vision, with the advanced stage of dry AMD and wet AMD having a more significant impact on vision and even causing blindness. Currently, patients with dry AMD are considered to be treated with antioxidants and other medications to slow down the progression of the disease, while treatment of wet AMD relies mainly on anti-vascular endothelial growth factor (VEGF) medication. Yong Liu, Ophthalmology Department, Air Force General Hospital